Pascale Dielenseger

503 total citations
15 papers, 317 citations indexed

About

Pascale Dielenseger is a scholar working on Oncology, Surgery and Dermatology. According to data from OpenAlex, Pascale Dielenseger has authored 15 papers receiving a total of 317 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 6 papers in Surgery and 4 papers in Dermatology. Recurrent topics in Pascale Dielenseger's work include Nausea and vomiting management (5 papers), Anesthesia and Pain Management (4 papers) and Cancer Treatment and Pharmacology (4 papers). Pascale Dielenseger is often cited by papers focused on Nausea and vomiting management (5 papers), Anesthesia and Pain Management (4 papers) and Cancer Treatment and Pharmacology (4 papers). Pascale Dielenseger collaborates with scholars based in France, United Kingdom and Germany. Pascale Dielenseger's co-authors include Annie Young, Mark Clemons, Eric Roeland, George Dranitsaris, Matti Aapro, Lee S. Schwartzberg, Karin Jordan, Alex Molassiotis, Florian Scotté and Élisabeth Carola and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and Supportive Care in Cancer.

In The Last Decade

Pascale Dielenseger

13 papers receiving 309 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pascale Dielenseger France 6 159 113 99 47 46 15 317
Vithusha Ganesh Canada 12 136 0.9× 132 1.2× 64 0.6× 20 0.4× 49 1.1× 26 314
Sherlyn Vuong Canada 11 148 0.9× 166 1.5× 104 1.1× 29 0.6× 85 1.8× 16 382
Vivianne Shih Singapore 10 65 0.4× 131 1.2× 32 0.3× 29 0.6× 38 0.8× 20 316
Lisa Lohr United States 5 72 0.5× 45 0.4× 41 0.4× 21 0.4× 61 1.3× 12 316
Toshihiro Hama Japan 11 91 0.6× 156 1.4× 25 0.3× 18 0.4× 67 1.5× 48 359
D. Berchery France 4 131 0.8× 132 1.2× 364 3.7× 162 3.4× 47 1.0× 5 509
Gilles Breysacher France 6 47 0.3× 169 1.5× 53 0.5× 80 1.7× 86 1.9× 17 237
Kamile Sılay Türkiye 11 42 0.3× 96 0.8× 107 1.1× 71 1.5× 75 1.6× 35 326
Rajiv Panikkar United States 7 21 0.1× 97 0.9× 100 1.0× 47 1.0× 43 0.9× 14 258
Carol Viele United States 10 66 0.4× 258 2.3× 20 0.2× 20 0.4× 151 3.3× 23 418

Countries citing papers authored by Pascale Dielenseger

Since Specialization
Citations

This map shows the geographic impact of Pascale Dielenseger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pascale Dielenseger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pascale Dielenseger more than expected).

Fields of papers citing papers by Pascale Dielenseger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pascale Dielenseger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pascale Dielenseger. The network helps show where Pascale Dielenseger may publish in the future.

Co-authorship network of co-authors of Pascale Dielenseger

This figure shows the co-authorship network connecting the top 25 collaborators of Pascale Dielenseger. A scholar is included among the top collaborators of Pascale Dielenseger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pascale Dielenseger. Pascale Dielenseger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Dréno, Brigitte, Kiarash Khosrotehrani, Julie Ryan Wolf, et al.. (2023). The role of dermocosmetics in the management of cancer-related skin toxicities: international expert consensus. Supportive Care in Cancer. 31(12). 672–672. 6 indexed citations
2.
Charalambous, Andreas, et al.. (2023). A review of growth and development of oncology nursing in six European countries. Annals of Palliative Medicine. 12(5). 1036–1046. 3 indexed citations
3.
Dréno, Brigitte, Kiarash Khosrotehrani, Delphine Kérob, et al.. (2023). Dermocosmetics in management of cancer-related skin toxicities: International expert consensus.. Journal of Clinical Oncology. 41(16_suppl). e24115–e24115. 1 indexed citations
4.
Selle, Frédèric, Jean‐Jacques Boffa, Gabriel Étienne, et al.. (2022). Gestion pratique des inhibiteurs de PARP : Un consensus national DELPHI. Bulletin du Cancer. 109(12). 1245–1261.
5.
Dielenseger, Pascale, Sussanne Börjeson, Cheryl Vidall, Annie Young, & Patrick Jahn. (2019). Evaluation of antiemetic practices for prevention of chemotherapy-induced nausea and vomiting (CINV): results of a European oncology nurse survey. Supportive Care in Cancer. 27(11). 4099–4106. 27 indexed citations
6.
Scotté, Florian, Paolo Bossi, Élisabeth Carola, et al.. (2018). Addressing the quality of life needs of older patients with cancer: a SIOG consensus paper and practical guide. Annals of Oncology. 29(8). 1718–1726. 106 indexed citations
7.
Dielenseger, Pascale, Sussanne Börjeson, Cheryl Vidall, Annie Young, & Patrick Jahn. (2017). Evaluation of Antiemetic Practices for Prevention of Chemotherapy-induced Nausea and Vomiting (CINV): Results of a European Oncology Nurse Survey. Annals of Oncology. 28. v547–v547. 1 indexed citations
8.
Dranitsaris, George, Alex Molassiotis, Mark Clemons, et al.. (2017). The development of a prediction tool to identify cancer patients at high risk for chemotherapy-induced nausea and vomiting. Annals of Oncology. 28(6). 1260–1267. 136 indexed citations
9.
Vidall, Cheryl, Pascale Dielenseger, C. Farrell, et al.. (2016). ecancermedicalscience. ecancermedicalscience. 5. 211–211. 13 indexed citations
10.
Dranitsaris, George, Alex Molassiotis, Mark Clemons, et al.. (2016). Identifying cancer patients at high risk for chemotherapy-induced nausea and vomiting (CINV): the development of a prediction tool. Annals of Oncology. 27. vi498–vi498. 4 indexed citations
11.
Wislez, Marie, David Malka, Jaafar Bennouna, et al.. (2014). Nouvelle perspective de traitement dans le cancer bronchique non à petites cellules (CBNPC). Place de l’afatinib : un inhibiteur oral et irréversible de la famille ErbB. Bulletin du Cancer. 101(6). 647–652. 8 indexed citations
12.
Jensen, Bente Thoft, et al.. (2011). Taking the lead – Sharing best practice in intravenous bisphosphonate use in urological cancers. European Journal of Oncology Nursing. 16(1). 42–53. 5 indexed citations
13.
Rosmorduc, Olivier, Christine Chevreau, Pascale Dielenseger, et al.. (2010). Bon usage du sorafénib chez les patients pris en charge pour un carcinome hépatocellulaire ou un cancer du rein. Gastroentérologie Clinique et Biologique. 34(3). 161–167. 2 indexed citations
14.
Dielenseger, Pascale, Jean-Marie Dilhuydy, Jean‐Yves Blay, et al.. (2006). [SOR SAVOIR PATIENT Cancer and fatigue. Information dedicated to cancer patients and relatives].. PubMed. 93(12). 1213–27. 5 indexed citations
15.
Krakowski, I., et al.. (2005). Pain related to repeated invasive procedures in oncology: Improvement of management between 1998 and 2004. Journal of Clinical Oncology. 23(16_suppl). 8247–8247.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026